نتایج جستجو برای: hbf

تعداد نتایج: 869  

Journal: :international journal of hematology-oncology and stem cell research 0
majid farshdousti hagh division of laboratory hematology and blood banking, faculty of medicine, tabriz university of medical sciences, tabrez, iran ali dehghani fard department of hematology and blood banking, faculty of medical sciences, tarbiat modares university,tehran, iran najmaldin saki research center of thalassemia and hemoglobinopathies, ahvaz jundishapur university of medical sciences, ahvaz, iran mohammad shahjahani department of hematology and blood banking, faculty of medical sciences, tarbiat modares university,tehran, iran saied kaviani department of hematology and blood banking, faculty of medical sciences, tarbiat modares university,tehran, iran

hemoglobin f (hbf, α 2 γ 2 ) is a major contributor to the clinical heterogeneity and ameliorating agent observed in patients with the β-globin disorders including β-thalassemia and sickle cell disease (scd). during fetal life, hbf is the major hemoglobin but is largely substituted by adult hemoglobin (hba, α 2 β 2 ) following a globin expression switch after birth. increased γ-globin expressio...

Journal: :American journal of physiology. Heart and circulatory physiology 2013
Dhananjay K Kaul Mary E Fabry Sandra M Suzuka Xiaoqin Zhang

Chronic inflammation is a salient feature of sickle cell disease (SCD) and transgenic-knockout sickle (BERK) mice. Inflammation is implicated in the activation of hypoxia-inducible factor-1α (HIF-1α) under normoxic conditions. We hypothesize that, in SCD, inflammation coupled with nitric oxide (NO) depletion will induce expression of HIF-1α, a transcription factor with wide-ranging effects incl...

Journal: :Blood 1994
R S Franco R Barker-Gear M A Miller S M Williams C H Joiner D L Rucknagel

A subset of sickle cells have an increased density at the reticulocyte stage of development, indicating that they are either abnormally dense upon release from the bone marrow or become dense quickly in the circulation. These cells are of interest because they most likely have severely disrupted cation regulation and a short lifespan. Based on the distribution of fetal hemoglobin (HbF) in the d...

Journal: :American journal of hematology 2015
Siana Nkya Mtatiro Julie Makani Bruno Mmbando Swee Lay Thein Stephan Menzel Sharon E Cox

Fetal hemoglobin (HbF) is a recognized modulator of sickle cell disease (SCD) severity. HbF levels are strongly influenced by genetic variants at three major genetic loci, Xmn1-HBG2, HMIP-2, and BCL11A, but the effect of these loci on the hematological phenotype in SCD, has so far not been investigated. In a cohort of individuals with SCD in Tanzania (HbSS and HbS/β° thalassemia, n = 726, aged ...

Journal: :African health sciences 2006
Dominic Edoh Charles Antwi-Bosaiko Dominic Amuzu

BACKGROUND Fetal hemoglobin has been implicated in the modulation of sickle cell crisis though it is functional during infancy. OBJECTIVE The purpose of this study was to determine the waning time of fetal hemoglobin (HbF) and its persistence in later life. METHOD Ninety infants aged 0-12 months, admitted at hospital, were tested for their HbF levels. Adult patients numbering 690 were also ...

Journal: :Anesthesiology 2001
T Kazama K Ikeda K Morita T Ikeda M Kikura S Sato

BACKGROUND Propofol induction dose is variable and depends on many factors, including initial volume of distribution and early disposition. The authors hypothesized that preadministration blood distribution volumes, cardiac output (CO), and hepatic blood flow (HBF) could be examined to establish a propofol induction dose. METHODS Propofol dose required to reach loss of consciousness, when inf...

2004
Natarajan V. Bhanu Tiffany A. Trice Y. Terry Lee Nicole M. Gantt Patricia Oneal Joseph D. Schwartz Pierre Noel Jeffery L. Miller

We systematically compared cytokinemediated increasesordecreases inproliferation with globin gene and protein expression in adult human erythroblasts. Despite their opposite effects on growth, stem cell factor (SCF) and transforming growth factorbeta (TGF-B) had synergistic effects with respect to fetal hemoglobin (HbF): average HbF/HbF adult hemoglobin (HbA) ratio in erythropoietin (EPO) 1.4 1...

Journal: :Evidence-based Complementary and Alternative Medicine : eCAM 2009
Nicoletta Bianchi Cristina Zuccato Ilaria Lampronti Monica Borgatti Roberto Gambari

The objective of this review is to present examples of lead compounds identified from biological material (fungi, plant extracts and agro-industry material) and of possible interest in the field of a pharmacological approach to the therapy of beta-thalassemia using molecules able to stimulate production of fetal hemoglobin (HbF) in adults. Concerning the employment of HbF inducers as potential ...

2011
Ines Paule Hind Sassi Anoosha Habibi Kim PD Pham Dora Bachir Frédéric Galactéros Pascal Girard Anne Hulin Michel Tod

BACKGROUND Hydroxyurea (HU) is the first approved pharmacological treatment of sickle cell anemia (SCA). The objectives of this study were to develop population pharmacokinetic(PK)-pharmacodynamic(PD) models for HU in order to characterize the exposure-efficacy relationships and their variability, compare two dosing regimens by simulations and develop some recommendations for monitoring the tre...

وکیلی, مسعود, یاوریان, مجید,

  Hydroxyurea (HU) enhances the production of fetal hemoglobin (HbF) and on the other hand this event can decreases the frequency of painful crises in sickle cell anemia (SCA). We studied the efficiency of HU in reducing painful crises and it’s effect on HbF production rate and on other hematologic values in 40 SCA patients. Median age of patients was 20 years. Eighteen were male and 22 were fe...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید